EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A photocontrolled one-pot isothermal amplification and CRISPR-Cas12a assay for rapid detection of SARS-CoV-2 Omicron variants

Qian Sun iD, Hongqing Lin, Yuan Li, Liping Yuan, Baisheng Li iD, Yunan Ma, Haiying Wang, Xiaoling Deng, Hongliang Chen, Shixing Tang iD

Microbiology Spectrum · 05.03.2024 · 12 (3)

DOI: 10.1128/spectrum.03645-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 05.03.2024. Verfasst von Qian Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Epidemiology, School of Public Health, Southern Medical University, G…. Hauptthemen laut MEDLINE: COVID-19, Nucleic Acids. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Major Science and Technology Projects of China (National Major Science and Technology Project of China).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR-Cas technology has widely been applied to detect single-nucleotide mutation and is considered as the next generation of molecular diagnostics. We previously reported the combination of nucleic acid amplification (NAA) and CRISPR-Cas12a system to distinguish major severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. However, the mixture of NAA and CRISPR-Cas12a reagents in one tube could interfere with the efficiency of NAA and CRISPR-Cas12a cleavage, which in turn affects the detection sensitivity. In the current study, we employed a novel photoactivated CRISPR-Cas12a strategy integrated with recombinase polymerase amplification (RPA) to develop one-pot RPA/CRISPR-Cas12a genotyping assay for detecting SARS-CoV-2 Omicron sub-lineages. The new system overcomes the potential inhibition of RPA due to early CRISPR-Cas12a activation and cleavage of the target template in traditional one-pot assay using photocleavable p-RNA, a complementary single-stranded RNA to specifically bind crRNA and precisely block Cas12a activation. The detection can be finished in one tube at 39℃ within 1 h and exhibits a low limit of detection of 30 copies per reaction. Our results demonstrated that the photocontrolled one-pot RPA/CRISPR-Cas12a assay could effectively identify three signature mutations in the spike gene of SARS-CoV-2 Omicron variant, namely, R346T, F486V, and 49X, and distinguish Omicron BA.1, BA.5.2, and BF.7 sub-lineages. Furthermore, the assay achieved a sensitivity of 97.3% and a specificity of 100.0% and showed a concordance of 98.3% with Sanger sequencing results. IMPORTANCE We successfully developed one-pot recombinase polymerase amplification/CRISPR-Cas12a genotyping assay by adapting photocontrolled CRISPR-Cas technology to optimize the conditions of nucleic acid amplification and CRISPR-Cas12a-mediated detection. This innovative approach was able to quickly distinguish severe acute respiratory syndrome coronavirus 2 Omicron variants and can be readily modified for detecting any nucleic acid mutations. The assay system demonstrates excellent clinical performance, including rapid detection, user-friendly operations, and minimized risk of contamination, which highlights its promising potential as a point-of-care testing for wide applications in resource-limiting settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Nucleic AcidsHumansCRISPR-Cas SystemsSARS-CoV-2RecombinasesRNA

Stichwörter der Autor:innen

CRISPR-Cas12aOmicron variantSARS-CoV-2genotypingisothermal amplificationone-pot assayphotocleavage

Substanzen

RecombinasesNucleic AcidsRNA

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Tropical Disease Research, Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.
  • Institute of Pathogenic Microbiology, Guangdong Provincial Center for Disease Control and Prevention, Guangdong Workstation for Emerging Infectious Disease Control and Prevention, Chinese Academy of Medical Sciences, Gu…
  • Department of Clinical Microbiology Laboratory, Chenzhou No. 1 People's Hospital, Chenzhou, China.
  • Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.

ORCID-Profile: Qian Sun, Baisheng Li, Shixing Tang

Förderung

  • MOST | National Major Science and Technology Projects of China (National Major Science and Technology Project of China)

Zitieren

APA

Sun, Q., Lin, H., Li, Y., Yuan, L., Li, B., Ma, Y., Wang, H., Deng, X., Chen, H., & Tang, S. (2024). A photocontrolled one-pot isothermal amplification and CRISPR-Cas12a assay for rapid detection of SARS-CoV-2 Omicron variants. Microbiology Spectrum, 12(3). https://doi.org/10.1128/spectrum.03645-23

Vancouver

Sun Q, Lin H, Li Y, Yuan L, Li B, Ma Y, et al. A photocontrolled one-pot isothermal amplification and CRISPR-Cas12a assay for rapid detection of SARS-CoV-2 Omicron variants. Microbiology Spectrum. 2024;12(3). doi:10.1128/spectrum.03645-23

BibTeX
@article{Sun2024,
  author = {Sun, Qian and Lin, Hongqing and Li, Yuan and Yuan, Liping and Li, Baisheng and Ma, Yunan and Wang, Haiying and Deng, Xiaoling and Chen, Hongliang and Tang, Shixing},
  title = {A photocontrolled one-pot isothermal amplification and CRISPR-Cas12a assay for rapid detection of SARS-CoV-2 Omicron variants},
  journal = {Microbiology Spectrum},
  year = {2024},
  volume = {12},
  number = {3},
  doi = {10.1128/spectrum.03645-23}
}
Kostenlos starten →